BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14981797)

  • 21. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009.
    Goldhirsch A; Ingle JN; Gelber RD; Coates AS; Thürlimann B; Senn HJ;
    Ann Oncol; 2009 Aug; 20(8):1319-29. PubMed ID: 19535820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New role of endocrine therapy in breast cancer.
    Kennedy BJ
    Int J Radiat Oncol Biol Phys; 1978; 4(5-6):469-72. PubMed ID: 689948
    [No Abstract]   [Full Text] [Related]  

  • 23. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
    Nesković-Konstantinović ZB; Nikolić-Vukosavljević DB; Branković-Magić MV; Mitrovic LB; Spuzić I
    Neoplasma; 2000; 47(2):107-13. PubMed ID: 10985476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steroid receptors in early breast cancer: value in prognosis.
    Nicholson RI; Campbell FC; Blamey RW; Elston CW; George D; Griffiths K
    J Steroid Biochem; 1981 Dec; 15():193-9. PubMed ID: 7339245
    [No Abstract]   [Full Text] [Related]  

  • 25. Solving the puzzle of hormone-dependent breast cancer.
    Santen RJ
    Trans Am Clin Climatol Assoc; 1992; 103():164-75. PubMed ID: 1413376
    [No Abstract]   [Full Text] [Related]  

  • 26. Steroid receptors in human breast cancer.
    McGuire WL
    Cancer Res; 1978 Nov; 38(11 Pt 2):4289-91. PubMed ID: 698967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer consensus meetings: vive la difference?
    Davidson NE; Levine M
    J Clin Oncol; 2002 Apr; 20(7):1719-20. PubMed ID: 11919226
    [No Abstract]   [Full Text] [Related]  

  • 28. [Tamoxifen: modern drug therapy of estrogen-dependent breast tumors].
    Jovanović-Mićić D; Beleslin DB; Nikolić SS
    Med Pregl; 1996; 49(7-8):287-90. PubMed ID: 8926945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant hormonal therapy for premenopausal women with breast cancer.
    Emens LA; Davidson NE
    Clin Cancer Res; 2003 Jan; 9(1 Pt 2):486S-94S. PubMed ID: 12538505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrine therapy of breast cancer. A background.
    Nordenskjöld B
    Acta Oncol; 1990; 29(3):367-9. PubMed ID: 2194538
    [No Abstract]   [Full Text] [Related]  

  • 31. Selecting adjuvant endocrine therapy for breast cancer.
    Eneman JD; Wood ME; Muss HB
    Oncology (Williston Park); 2004 Dec; 18(14):1733-44, discussion 1744-5, 1748, 1751-4. PubMed ID: 15700624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings of the 1st International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer. Boston, Massachusetts, March 29-30, 1996.
    Urology; 1997 Mar; 49(3A Suppl):1-118; quiz 121-3. PubMed ID: 9123726
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecular heterogeneity of cytosolic forms of estrogen receptors from human breast tumors.
    Kute TE; Heidemann P; Wittliff JL
    Cancer Res; 1978 Nov; 38(11 Pt 2):4307-13. PubMed ID: 698972
    [No Abstract]   [Full Text] [Related]  

  • 34. Estrogen receptor variants in human breast cancer.
    Murphy LC
    Mol Cell Endocrinol; 1990 Dec; 74(2):C83-6. PubMed ID: 2090511
    [No Abstract]   [Full Text] [Related]  

  • 35. Adrenalectomy for palliation of metastatic breast cancer.
    Dao TL
    Int J Radiat Oncol Biol Phys; 1978; 4(5-6):473-6. PubMed ID: 80401
    [No Abstract]   [Full Text] [Related]  

  • 36. Some comments on the necessity of receptor determination in human breast cancer.
    Jonat W; Maass H
    Cancer Res; 1978 Nov; 38(11 Pt 2):4305-6. PubMed ID: 698971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
    Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N
    Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic versus therapeutic castration in the total treatment of breast cancer.
    Lewison EF
    Int J Radiat Oncol Biol Phys; 1978; 4(5-6):477-80. PubMed ID: 357357
    [No Abstract]   [Full Text] [Related]  

  • 39. Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.
    Jia X; Hong Q; Lei L; Li D; Li J; Mo M; Wang Y; Shao Z; Shen Z; Cheng J; Liu G
    Oncotarget; 2015 Apr; 6(11):8648-62. PubMed ID: 25929338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen-dependent tumors. Overview.
    Ogata E
    Oncology; 1998 Dec; 55 Suppl 1():3-4. PubMed ID: 9935360
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.